What is Azalea Therapeutics worth?
$153.0Mlast known valuation
Azalea Therapeutics last raised $65.0M in its Early Stage VC (Series A) (Oct 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Azalea Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2025 | Early Stage VC (Series A) | $65.0M | ▮ | ▮ |
How Azalea Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Azalea Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Azalea Therapeutics worth?
- Azalea Therapeutics's last known valuation is $153.0M.
- How much has Azalea Therapeutics raised?
- Azalea Therapeutics has raised $82.0M in total funding across 1 recorded rounds.
- When did Azalea Therapeutics last raise?
- Azalea Therapeutics last raised in Oct 2025 (Early Stage VC (Series A)), raising $65.0M.